MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CULVENOR, A. J.
Right arrow Articles by JARROTT, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CULVENOR, A. J.
Right arrow Articles by JARROTT, B.

Molecular Pharmacology, Vol 15, 86-98, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Reduction of Aromatic L-Amino Acid Decarboxylase Protein in Rats after Chronic Administration of Alpha-Methyldopa

ANNE J. CULVENOR 1 and B. JARROTT 1

1 Unit of Clinical Pharmacology and Therapeutics, University of Melbourne, Austin Hospital, Heidelberg, Victoria 3084, Australia

The effect of chronic administration of agr-methyldopa (400 mg/kg per day for seven days) to rats on the activity and amount of aromatic L-amino acid decarboxylase (EC 4.1.1.28) was studied. Aromatic L-amino acid decarboxylase activity measured in dialyzed supernatants was substantially reduced relative to control levels in all tissues analyzed. This effect was not due to the presence of substances inhibiting enzyme activity or to an alteration in the affinity of aromatic L-amino acid decarboxylase for its substrate, L-dopa. The amount of aromatic L-amino acid decarboxylase in dialyzed supernatants was estimated by immunotitration with a specific antibody raised to the enzyme purified from hog kidney cortex. Chronic administration of agr-methyldopa caused a substantial decrease in the amount of aromatic L-amino acid decarboxylase protein in all tissues. The extent of the reduction in enzyme activity and enzyme protein was very similar within each tissue. The turnover of total soluble protein, measured by double isotope incorporation, was not altered in heart, brain or liver after agr-methyldopa administration, although small reductions in adrenal and kidney soluble protein turnover were detected. Potential mechanisms for the reduction of aromatic L-amino acid decarboxylase levels are discussed.

Submitted on August 11, 1978
Accepted on August 15, 1978







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics